Center for Engineered Therapeutics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, USA.
Division of Health Science and Technology, Harvard-Massachusetts Institute of Technology, Massachusetts Institute of Technology, Boston, MA 02139, USA.
Int J Mol Sci. 2021 Jun 7;22(11):6161. doi: 10.3390/ijms22116161.
The interaction of tumor cells with blood vessels is one of the key steps during cancer metastasis. Metastatic cancer cells exhibit phenotypic state changes during this interaction: (1) they form tunneling nanotubes (TNTs) with endothelial cells, which act as a conduit for intercellular communication; and (2) metastatic cancer cells change in order to acquire an elongated phenotype, instead of the classical cellular aggregates or mammosphere-like structures, which it forms in three-dimensional cultures. Here, we demonstrate mechanistically that a siRNA-based knockdown of the exocyst complex protein Sec3 inhibits TNT formation. Furthermore, a set of pharmacological inhibitors for Rho GTPase-exocyst complex-mediated cytoskeletal remodeling is introduced, which inhibits TNT formation, and induces the reversal of the more invasive phenotype of cancer cell (spindle-like) into a less invasive phenotype (cellular aggregates or mammosphere). Our results offer mechanistic insights into this nanoscale communication and shift of phenotypic state during cancer-endothelial interactions.
肿瘤细胞与血管的相互作用是癌症转移过程中的关键步骤之一。在这种相互作用中,转移性癌细胞表现出表型状态的变化:(1)它们与内皮细胞形成隧道纳米管(TNTs),作为细胞间通讯的通道;(2)转移性癌细胞发生变化,以获得拉长的表型,而不是在三维培养中形成的经典细胞聚集或类乳腺球体结构。在这里,我们从机制上证明了基于 siRNA 的外泌体复合物蛋白 Sec3 的敲低抑制了 TNT 的形成。此外,还引入了一组用于 Rho GTPase-外泌体复合物介导的细胞骨架重塑的药理学抑制剂,它抑制了 TNT 的形成,并诱导癌细胞(纺锤形)更具侵袭性的表型向侵袭性较低的表型(细胞聚集或类乳腺球体)逆转。我们的结果为这种纳米级通讯和癌症-内皮相互作用过程中表型状态的转变提供了机制上的见解。